Publications by authors named "Junichi Eguchi"

Claim this Profile
U
Usefulness of a One-step Semi-deployment Flushing and Stenting Technique in Endoscopic Transpapillary Gallbladder Drainage for Acute Cholecystitis (With Video).
Yuki Kawasaki, Jun Ushio, Hisaki Kato, Kazuya Sumi, Yuki Shibata, Junichi Eguchi

DEN Open· April 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Propofol-alone sedative efficacy in observational biliopancreatic endoscopic ultrasound.
Hisaki Kato, Yuki Kawasaki, Kazuya Sumi, Yuki Shibata, Norihiro Nomura, Junichi Eguchi

DEN Open· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance of an ambulatory electroencephalogram sleep monitor in patients with psychiatric disorders.
Seiko Miyata, Kunihiro Iwamoto, Masahiro Banno, Junichi Eguchi, Satoshi Kaneko

J Sleep Res· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decreased expression of interferon-stimulated genes in B cells of patients with chronic hepatitis C during interferon-free therapy potentially suggests the eradication of hepatitis C virus in the B cells: A cohort study.
Jun Arai, Takayoshi Ito, Yuu Shimozuma, Manabu Uchikoshi, Yoko Nakajima, Junichi Eguchi, Yoshio Deguchi

Health Sci Rep· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Ability for Basic Movement Scale II Can Predict Functional Outcome and Discharge Destination in Stroke Patients.
De Gang Yang, Rui Gu, Shin Sato, Fei Zheng, Mitsuhiro Sano, Junichi Eguchi

J Stroke Cerebrovasc Dis· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Candidatus Mycoplasma haemohominis in Human, Japan.
Norimichi Hattori, Makoto Kuroda, Harutaka Katano, Takahiro Takuma, Takayoshi Ito, Junichi Eguchi

Emerg Infect Dis· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The selective GSK3 inhibitor, SAR502250, displays neuroprotective activity and attenuates behavioral impairments in models of neuropsychiatric symptoms of Alzheimer's disease in rodents.
Guy Griebel, Jeanne Stemmelin, Mati Lopez-Grancha, Denis Boulay, Gerald Boquet, Junichi Eguchi

Sci Rep· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three cases of histologically proven hepatic epithelioid hemangioendothelioma evaluated using a second-generation microbubble contrast medium in ultrasonography: case reports.
Jun Arai, Yuu Shimozuma, Yumi Otoyama, Ikuya Sugiura, Yoko Nakajima, Junichi Eguchi

BMC Gastroenterol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced B-cell differentiation driven by advanced cirrhosis resulting in hyperglobulinemia.
Hiroyoshi Doi, Eiichi Hayashi, Jun Arai, Masayuki Tojo, Kenichi Morikawa, Junichi Eguchi

J Gastroenterol Hepatol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of novel 2-(4-aryl-2-methylpiperazin-1-yl)-pyrimidin-4-ones as glycogen synthase kinase-3β inhibitors.
Toshiyuki Kohara, Kazuki Nakayama, Kazutoshi Watanabe, Shin-Ichi Kusaka, Daiki Sakai, Jun-Ichi Eguchi

Bioorg Med Chem Lett· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of novel 2-(3-phenylpiperazin-1-yl)-pyrimidin-4-ones as glycogen synthase kinase-3β inhibitors.
Yoshihiro Usui, Fumiaki Uehara, Shinsuke Hiki, Kazutoshi Watanabe, Hiroshi Tanaka, Jun-Ichi Eguchi

Bioorg Med Chem Lett· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Study of Personalized Peptide Vaccination with Both a Hepatitis C Virus-Derived Peptide and Peptides from Tumor-Associated Antigens for the Treatment of HCV-Positive Advanced Hepatocellular Carcinoma Patients.
Shigeru Yutani, Kazuomi Ueshima, Kazumichi Abe, Atsushi Ishiguro, Junichi Eguchi

J Immunol Res· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased expression of immuno-inhibitory molecules on peripheral blood lymphocytes may suppress disease progression in autoimmune hepatitis.
Ayako Hiraide-Sasagawa, Kazumasa Hiroishi, Tomoe Shimazaki, Junichi Eguchi, Shigeaki Ishii

Hepatol Res· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-incision cholecystectomy in a patient with situs inversus totalis presenting with cholelithiasis: A case report.
Yoshio Deguchi, Keitaro Mitamura, Shunsuke Omotaka, Jun-ichi Eguchi, Dai Sakuma

Asian J Endosc Surg· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of novel 2-(alkylmorpholin-4-yl)-6-(3-fluoropyridin-4-yl)-pyrimidin-4(3H)-ones as orally-active GSK-3β inhibitors for Alzheimer's disease.
Kenji Fukunaga, Daiki Sakai, Kazutoshi Watanabe, Kazuki Nakayama, Toshiyuki Kohara, Jun-ichi Eguchi

Bioorg Med Chem Lett· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
6
6-(4-Pyridyl)pyrimidin-4(3H)-ones as CNS penetrant glycogen synthase kinase-3β inhibitors.
Fumiaki Uehara, Aya Shoda, Keiichi Aritomo, Kenji Fukunaga, Kazutoshi Watanabe, Jun-ichi Eguchi

Bioorg Med Chem Lett· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2-(2-Phenylmorpholin-4-yl)pyrimidin-4(3H)-ones; a new class of potent, selective and orally active glycogen synthase kinase-3β inhibitors.
Kenji Fukunaga, Fumiaki Uehara, Keiichi Aritomo, Aya Shoda, Shinsuke Hiki, Jun-ichi Eguchi

Bioorg Med Chem Lett· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune response of cytotoxic T lymphocytes and possibility of vaccine development for hepatitis C virus infection.
Kazumasa Hiroishi, Junichi Eguchi, Shigeaki Ishii, Ayako Hiraide, Masashi Sakaki

J Biomed Biotechnol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Iliopsoas abscess caused by Aspergillus fumigatus complicated by pulmonary aspergillosis.
Koichiro Yoshida, Hisashi Shoji, Takahiro Takuma, Junichi Eguchi, Michio Imawari

J Infect Chemother· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of Indoleamine-2,3-dioxygenase (IDO) in Glioblastoma Cells by Oncolytic Herpes Simplex Virus.
Bonnie Reinhart, Lucia Mazzacurati, Adriana Forero, Chang-Sook Hong, Junichi Eguchi

Adv Virol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-4 and CpG oligonucleotide therapy suppresses the outgrowth of tumors by activating tumor-specific Th1-type immune responses.
Atsushi Kajiwara, Hiroyoshi Doi, Junichi Eguchi, Shigeaki Ishii, Ayako Hiraide-Sasagawa

Oncol Rep· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclooxygenase-2 gene promoter polymorphisms affect susceptibility to hepatitis C virus infection and disease progression.
Masashi Sakaki, Reiko Makino, Kazumasa Hiroishi, Kumiko Ueda, Junichi Eguchi

Hepatol Res· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strong CD8(+) T-cell responses against tumor-associated antigens prolong the recurrence-free interval after tumor treatment in patients with hepatocellular carcinoma.
Kazumasa Hiroishi, Junichi Eguchi, Toshiyuki Baba, Tomoe Shimazaki, Shigeaki Ishii

J Gastroenterol· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Magnitude of CD8 T-cell responses against hepatitis C virus and severity of hepatitis do not necessarily determine outcomes in acute hepatitis C virus infection.
Hiroyoshi Doi, Kazumasa Hiroishi, Tomoe Shimazaki, Junichi Eguchi, Toshiyuki Baba

Hepatol Res· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dendritic cells stimulated with cytidine-phosphate-guanosine oligodeoxynucleotides and interferon-alpha-expressing tumor cells effectively reduce outgrowth of established tumors in vivo.
Ayako Hiraide, Kazumasa Hiroishi, Junichi Eguchi, Shigeaki Ishii, Hiroyoshi Doi

Cancer Sci· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis